Yiqun Sun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yiqun Sun has a total of 88 co-authors. Here are the top co-authors by number of shared publications:
- Lijun Shen
Department of Radiation Oncology, Fudan University Shanghai Cancer Center, China
9 shared publications - Tong Tong
Fudan University Shanghai Cancer Center
9 shared publications - Wenchao Gu
Department of Artificial Intelligence Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan
8 shared publications - Zhen Zhang
Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China
8 shared publications - Dakui Luo
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
7 shared publications - Di Zhou
Affiliation Department of Radiation Oncology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
7 shared publications
Latest Publications
- 25 September 2026
- Published by Springer Nature
- p. 168-178
ECLIPSE: EHR-Constrained Localized Inference for Pan-Tumor Segmentation
- 25 September 2026
- Published by Springer Nature
- p. 168-178
ECLIPSE: EHR-Constrained Localized Inference for Pan-Tumor Segmentation
- 6 September 2026
- Published by Springer Nature in Abdominal Radiology
- p. 1-9
T1 Mapping-Derived Extracellular Volume Fraction for Non-Invasive Assessment of Tumor-Stroma Ratio in Rectal Cancer
- 6 September 2026
- Published by Springer Nature in Abdominal Radiology
- p. 1-9
T1 Mapping-Derived Extracellular Volume Fraction for Non-Invasive Assessment of Tumor-Stroma Ratio in Rectal Cancer
- 1 May 2026
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 319 (2) , e251719
Interpretable MRI-based Multiparametric Radiomics for Preoperative Prediction of CMS4 Colorectal Cancer
In patients with colorectal cancer, a machine learning radiomics model based on preoperative multiparametric MRI predicted consensus molecular subtype 4 with strong performance and biologic interpretability supported by transcriptomic analyses.
- 1 May 2026
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 319 (2) , e251719
Interpretable MRI-based Multiparametric Radiomics for Preoperative Prediction of CMS4 Colorectal Cancer
In patients with colorectal cancer, a machine learning radiomics model based on preoperative multiparametric MRI predicted consensus molecular subtype 4 with strong performance and biologic interpretability supported by transcriptomic analyses.
- Open Access
- 17 March 2026
- Published by Springer Nature in Cancer Immunology, Immunotherapy
- Vol. 75 (4) , 113
Correction: Automatically quantifying spatial heterogeneity of immune and tumor hypoxia environment and predicting disease-free survival for patients with rectal cancer
- 17 March 2026
- Published by Springer Nature in Cancer Immunology, Immunotherapy
- Vol. 75 (4) , 113
Open AccessCorrection: Automatically quantifying spatial heterogeneity of immune and tumor hypoxia environment and predicting disease-free survival for patients with rectal cancer
- Open Access
- 2 December 2025
- Published by Springer Nature in International Journal of Colorectal Disease
- Vol. 40 (1) , 244
MRI-defined high-risk rectal cancer patients: comparison of treatment response and survival outcomes between total neoadjuvant therapy and neoadjuvant chemoradiotherapy—a propensity score matched analysis
Purpose This study evaluated whether total neoadjuvant therapy (TNT), compared to neoadjuvant chemoradiotherapy (nCRT), improves response and prognosis in magnetic resonance imaging (MRI)–defined high-risk patients with locally advanced rectal cancer (LARC). Methods This retrospective cohort study ultimately included 791 patients with pathologically confirmed rectal cancer who underwent baseline rectal MRI at our institution between 2015 and 2022. Independent MRI-based prognostic risk factors were identified through multivariable Cox regression analysis. Propensity score matching (PSM) was employed to control for confounding variables, followed by survival and treatment response analyses between groups. Results The Cox model revealed that MR-based T4 stage and extramural venous invasion (EMVI) status significantly impacted overall survival (OS), whereas tumor location and mesorectal fascia invasion (MRF) status served as important predictors of disease-free survival (DFS). After PSM, the MRI-defined TNT group exhibited a significantly higher clinical complete response (cCR) rate (25.8% vs. 4.0%, p < 0.001), thus leading to more frequent adoption of the watch and wait (W&W) strategy. Furthermore, Kaplan–Meier (KM) curve analysis ultimately confirmed that, compared with the nCRT group, the TNT group exhibited superior OS (HR = 0.48, 95% CI 0.27–0.86) and DFS (HR = 0.62, 95% CI 0.39–1). Conclusion In MRI-defined high-risk LARC patients, TNT could improve the survival trend while increasing the likelihood of organ preservation without exacerbating surgical complexity. These findings emphasize the fact that TNT should be prioritized for the high-risk MRI-defined population to achieve enhanced local tumor control, sustained therapeutic efficacy, and prolonged survival.
- 2 December 2025
- Published by Springer Nature in International Journal of Colorectal Disease
- Vol. 40 (1) , 244
Open AccessMRI-defined high-risk rectal cancer patients: comparison of treatment response and survival outcomes between total neoadjuvant therapy and neoadjuvant chemoradiotherapy—a propensity score matched analysis
Purpose This study evaluated whether total neoadjuvant therapy (TNT), compared to neoadjuvant chemoradiotherapy (nCRT), improves response and prognosis in magnetic resonance imaging (MRI)–defined high-risk patients with locally advanced rectal cancer (LARC). Methods This retrospective cohort study ultimately included 791 patients with pathologically confirmed rectal cancer who underwent baseline rectal MRI at our institution between 2015 and 2022. Independent MRI-based prognostic risk factors were identified through multivariable Cox regression analysis. Propensity score matching (PSM) was employed to control for confounding variables, followed by survival and treatment response analyses between groups. Results The Cox model revealed that MR-based T4 stage and extramural venous invasion (EMVI) status significantly impacted overall survival (OS), whereas tumor location and mesorectal fascia invasion (MRF) status served as important predictors of disease-free survival (DFS). After PSM, the MRI-defined TNT group exhibited a significantly higher clinical complete response (cCR) rate (25.8% vs. 4.0%, p < 0.001), thus leading to more frequent adoption of the watch and wait (W&W) strategy. Furthermore, Kaplan–Meier (KM) curve analysis ultimately confirmed that, compared with the nCRT group, the TNT group exhibited superior OS (HR = 0.48, 95% CI 0.27–0.86) and DFS (HR = 0.62, 95% CI 0.39–1). Conclusion In MRI-defined high-risk LARC patients, TNT could improve the survival trend while increasing the likelihood of organ preservation without exacerbating surgical complexity. These findings emphasize the fact that TNT should be prioritized for the high-risk MRI-defined population to achieve enhanced local tumor control, sustained therapeutic efficacy, and prolonged survival.
- Open Access
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S2 from Organ Preservation via Immunotherapy-Based Total Neoadjuvant Therapy in Early Low Rectal Cancer (TORCH-E): A Multicenter, Open-label, Single-Arm, Phase II Study
Duration of cCR in each individual patient who adopted WW
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S2 from Organ Preservation via Immunotherapy-Based Total Neoadjuvant Therapy in Early Low Rectal Cancer (TORCH-E): A Multicenter, Open-label, Single-Arm, Phase II Study
Duration of cCR in each individual patient who adopted WW
- Open Access
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S3 from Organ Preservation via Immunotherapy-Based Total Neoadjuvant Therapy in Early Low Rectal Cancer (TORCH-E): A Multicenter, Open-label, Single-Arm, Phase II Study
Characteristics of Patients Developing Tumor Recurrence
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S3 from Organ Preservation via Immunotherapy-Based Total Neoadjuvant Therapy in Early Low Rectal Cancer (TORCH-E): A Multicenter, Open-label, Single-Arm, Phase II Study
Characteristics of Patients Developing Tumor Recurrence
- Open Access
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S4 from Organ Preservation via Immunotherapy-Based Total Neoadjuvant Therapy in Early Low Rectal Cancer (TORCH-E): A Multicenter, Open-label, Single-Arm, Phase II Study
Postoperative complications according to Clavien- Dindo classification
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S4 from Organ Preservation via Immunotherapy-Based Total Neoadjuvant Therapy in Early Low Rectal Cancer (TORCH-E): A Multicenter, Open-label, Single-Arm, Phase II Study
Postoperative complications according to Clavien- Dindo classification
- Open Access
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S1 from Organ Preservation via Immunotherapy-Based Total Neoadjuvant Therapy in Early Low Rectal Cancer (TORCH-E): A Multicenter, Open-label, Single-Arm, Phase II Study
Representativeness of Study Participants
- 1 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S1 from Organ Preservation via Immunotherapy-Based Total Neoadjuvant Therapy in Early Low Rectal Cancer (TORCH-E): A Multicenter, Open-label, Single-Arm, Phase II Study
Representativeness of Study Participants